Literature DB >> 22932494

Acquired nasopharyngeal stenosis in a patient with sarcoidosis.

J R Brodsky1, S A Tatum, R T Kelley.   

Abstract

INTRODUCTION: Acquired nasopharyngeal stenosis typically occurs as a result of surgery or irradiation of the nasopharynx. Sarcoidosis has numerous manifestations in the head and neck region, although an association with nasopharyngeal stenosis has not previously been reported. CASE REPORT: A 40-year-old man with sarcoidosis developed severe acquired nasopharyngeal stenosis. This was successfully managed with balloon dilatation, followed by pharyngoplasty with local pharyngeal flap reconstruction.
CONCLUSION: This report is intended to prompt consideration of nasopharyngeal stenosis as a potential cause of nasal obstruction in patients with sarcoidosis, and to draw attention to the need to consider sarcoidosis in the differential diagnosis of patients with acquired nasopharyngeal stenosis. We also demonstrate the viability of pharyngoplasty in the management of nasopharyngeal stenosis in the setting of sarcoidosis.

Entities:  

Mesh:

Year:  2012        PMID: 22932494     DOI: 10.1017/S0022215112001776

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Nasopharyngeal sarcoidosis: case reports and literature review.

Authors:  Giacomo Benettini; Luca Bruschini; Giacomo Fiacchini; Matteo Vianini; Silvia De Santi; Lucrezia Sparacino; Valentina Donati; Stefano Berrettini; Andrea De Vito
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-03-31       Impact factor: 0.670

2.  Acquired Nasopharyngeal Stenosis Correction Using a Modified Palatal Flaps Technique in Obstructive Sleep Apnea (OSA) Patients.

Authors:  Giovanni Cammaroto; Luigi Marco Stringa; Luca Cerritelli; Giulia Bianchi; Giuseppe Meccariello; Riccardo Gobbi; Giannicola Iannella; Giuseppe Magliulo; Henry Zhang; Ahmed Yassin Baghat; Francesco Galletti; Stefano Pelucchi; Francesco Stomeo; Muawya Bani Younes; Mohamed AlAjmi; Andrea De Vito; Claudio Vicini
Journal:  Int J Environ Res Public Health       Date:  2020-03-19       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.